Ghent University Academic Bibliography

Advanced

Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Tryponosoma cruzi infection: A vaccine candidate

GH FONTANELLA, Kristof De Vusser, Wouter Laroy, L DAURELIO, AL NOCITO, S REVELLI and Roland Contreras UGent (2008) VACCINE. 26(19). p.2322-2334
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
VACCINE
Vaccine
volume
26
issue
19
pages
2322-2334 pages
Web of Science type
Article
Web of Science id
000255922900004
JCR category
VETERINARY SCIENCES
JCR impact factor
3.298 (2008)
JCR rank
2/133 (2008)
JCR quartile
1 (2008)
ISSN
0264-410X
DOI
10.1016/j.vaccine.2008.02.060
language
English
UGent publication?
yes
classification
A1
id
416353
handle
http://hdl.handle.net/1854/LU-416353
date created
2008-05-30 13:25:00
date last changed
2016-12-19 15:45:25
@article{416353,
  author       = {FONTANELLA, GH and De Vusser, Kristof and Laroy, Wouter and DAURELIO, L and NOCITO, AL and REVELLI, S and Contreras, Roland},
  issn         = {0264-410X},
  journal      = {VACCINE},
  language     = {eng},
  number       = {19},
  pages        = {2322--2334},
  title        = {Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Tryponosoma cruzi infection: A vaccine candidate},
  url          = {http://dx.doi.org/10.1016/j.vaccine.2008.02.060},
  volume       = {26},
  year         = {2008},
}

Chicago
FONTANELLA, GH, Kristof De Vusser, Wouter Laroy, L DAURELIO, AL NOCITO, S REVELLI, and Roland Contreras. 2008. “Immunization with an Engineered Mutant Trans-sialidase Highly Protects Mice from Experimental Tryponosoma Cruzi Infection: A Vaccine Candidate.” Vaccine 26 (19): 2322–2334.
APA
FONTANELLA, G., De Vusser, K., Laroy, W., DAURELIO, L., NOCITO, A., REVELLI, S., & Contreras, R. (2008). Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Tryponosoma cruzi infection: A vaccine candidate. VACCINE, 26(19), 2322–2334.
Vancouver
1.
FONTANELLA G, De Vusser K, Laroy W, DAURELIO L, NOCITO A, REVELLI S, et al. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Tryponosoma cruzi infection: A vaccine candidate. VACCINE. 2008;26(19):2322–34.
MLA
FONTANELLA, GH, Kristof De Vusser, Wouter Laroy, et al. “Immunization with an Engineered Mutant Trans-sialidase Highly Protects Mice from Experimental Tryponosoma Cruzi Infection: A Vaccine Candidate.” VACCINE 26.19 (2008): 2322–2334. Print.